EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Scotts Miracle-Gro Co. (0L45) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Scotts Miracle-Gro Co. $31.37, price $49.42, upside -36.5%, quality 59 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Industrials · GB · Home US

SM Some data Sep 24, 2026

Scotts Miracle-Gro Co.

0L45 · LSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value $31.37 · Strongly overvalued (−36.5%)
!Quality 59/100
!Weak Growth (revenue 5y −3.7 %/yr)
!Thin margins · 3.2% net margin (TTM)
✓Negative equity (buybacks among others) · generates free cash flow
✓5.3% dividend yield · Well covered
✓Ranks above peers (5/8)
!Narrow moat 44/100
!Evidence only medium, so the estimate is less certain
!Weak on future: 25 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$206.41 $34.52 Fair Value $31.37 Feb 2018 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $34.52 – $206.41 · fair‑value band $17.85 – $53.68 · the $49.42 price screens above the $31.37 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Scotts Miracle-Gro Co. in your weekly email

Every Wednesday you see whether Scotts Miracle-Gro Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally.

Show more

The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. The company provides lawn care products, comprising lawn fertilizers, clover and grass seed products, spreaders, and other durable products, as well as lawn-related weed, pest, and disease control products; and gardening and landscape products, which include water-soluble and continuous-release plant foods, potting mixes, garden soils, mulches and ground cover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions. It also offers hydroponic products that help users to grow plants, flowers, and vegetables using little or no soil; lighting systems and components; insect, rodent, and weed control products for home areas; and non-selective weed killer products. The company sells its products under the Scotts, Turf Builder, Grower's Edge, EZ Seed, PatchMaster, Thick'R Lawn, GrubEx, EdgeGuard, Whirl, Wizz, Miracle-Gro, LiquaFeed, Shake "N Feed, Hyponex, Earthgro, Miracle-Gro Organic, CAN-FAN, CAN-FILTERS, EcoPlus, Bug B Gon, Nature Scapes, Ortho, Miracle-Gro Performance Organics, Miracle-Gro Organic Choice, Whitney Farms, Ortho Max, Home Defense, Mother Earth, Botanicare, General Hydroponics, CYCO, Gavita, Agrolux, HydroLogic Purification System, Gro Pro, AeroGarden, Titan, Tomcat, Ortho Weed B Gon, Roundup, Groundclear, and Alchemist brands. It serves home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, and food and drug stores, as well as indoor gardening and hydroponic distributors, retailers, and growers. The company was formerly known as The Scotts Company. The Scotts Miracle-Gro Company was founded in 1868 and is headquartered in Marysville, Ohio.

Stock analysis

Scotts Miracle-Gro Co. (0L45) currently trades at $49.42, while our model-based Fair Value estimate is $31.37, 36.5% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $55.11 per share, and 7 of the 19 models we run sit above the $49.42 price.

Bear case: the Earnings-Based group reads lowest at $14.40, and 12 of the 19 models stay below the price. Evidence for this calculation is medium.

Scenario range: $17.85 (bear) to $53.68 (bull), the price of $49.42 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 59/100 (solid quality), in the Industrials sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Scotts Miracle-Gro Co. reported revenue of $3.4B in FY2025 versus $4.9B in FY2021, a compound −8.8%/yr. Reported net income was $145M in FY2025, compounding −27.0%/yr from FY2021.

Key figures

Market cap $2.9B · P/E ratio 0.1 · EPS (TTM) $7.12 · Dividend yield 5.3% · Net margin 4.3% · Return on equity −47.6% · Return on assets (EBIT) 11.8% · Operating margin 27.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 34% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −46% fair-value upside, at −37%, 0L45 screens cheaper than that median.

Fair Value models

Bear $17.85 Fair Value $31.37 Bull $53.68
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($4.48 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $27.93 $53.26 $87.74 78
Growth DCF $29.94 $53.80 $84.99 77
5Y EBITDA Exit $27.47 $59.92 $95.86 73
All 19 models by family
DCF Models
FCF DCF $27.93 $53.26 $87.74 78
Owner Earnings $0.8700 $16.00 $36.59 67
5Y Revenue Exit $20.37 $47.54 $80.77 69
5Y EBITDA Exit $27.47 $59.92 $95.86 73
5Y P/E Exit $8.62 $27.05 $45.06 67
10Y Revenue Exit $21.16 $45.32 $73.93 64
10Y EBITDA Exit $27.05 $53.42 $84.45 66
10Y P/E Exit $15.62 $31.92 $49.03 62
Earnings-Based
Graham-Dodd $17.85 $36.80 $46.46 66
EPV $7.08 $14.40 $20.72 70
Multiples
P/E Multiple $41.34 $55.11 $68.89 63
P/S Multiple $33.46 $44.62 $55.77 58
EV/EBIT $43.37 $70.92 $98.47 64
EV/EBITDA $37.14 $62.61 $88.09 65
EV/Revenue $19.71 $44.99 $70.27 51
Growth DCF
Growth DCF $29.94 $53.80 $84.99 77
Rev-Margin DCF $20.37 $48.57 $78.48 70
Economic Profit
ROIC Compounder $8.24 $17.86 $27.95 68
Growth Earnings
Growth-Adj P/E $30.19 $43.13 $56.07 67

Open the full fair value analysis →

Notify me when 0L45 reaches fair value

Put 0L45 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 59/100

Of which business quality 55 · Market factors (momentum, volatility) 18

Profitability 59
Margins and returns on capital today
Quality Growth 70
Are margins and returns improving?
Cashflow 63
Earnings quality: real cash, not paper profit
Fin. Strength 9
Balance sheet, leverage, solvency risk
Investment 98
Disciplined investing over empire-building
Low Volatility 22
Calm price path (market factor)
Momentum 21
Price trend over the last 3–12 months (market factor)
52W Momentum 9
Distance to the 52-week high (market factor)
Net Issuance 55
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−3.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.7%
Start year 2020 (pandemic). Over 10 years: +3.7% a year
Revenue growth 35 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.7%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−16.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−21.3%
Dividend (yield on the price)5.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−21.3% vs 0.6%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 11%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+0.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +14.8% a year for the price and −2.1% for the forecasts.
Forecast 2026 (sales)−0.1%
Forecast 2027 (sales)−0.1%
Projected 2028 (sales)+0.2%
Projected 2029 (sales)+0.4%
Projected 2030 (sales)+0.7%

0L45 screens overvalued: fair value 37% below the price. Compare with Linde plc →

Compare Scotts Miracle-Gro Co. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 696 stocks

Beats the industry median on 5/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 61 · Above median
Fair Value upside −37.9% · Below median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets 8.8% · Top 25%
Net margin (TTM) 3.2% · Below median
Operating margin (TTM) 27.7% · Top 25%
Growth and dividend
Revenue growth 5.0% · Below median
Dividend yield (TTM) 5.3% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (TTM) 0.1× · Cheapest 25%
P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)25 · sector 54
PAST (return on equity)0 · sector 26
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)100 · sector 29

VALUE 0: the price sits above our fair-value range.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $474.65 $441.72 −7%
The Sherwin-Williams Company SHW $330.44 $151.68 −54%
Ecolab Inc ECL $274.58 $96.56 −65%
Air Products and Chemicals, Inc APD $279.19 $121.30 −57%
Nan Ya Plastics Corporation 1303 238.00 TWD 234.23 TWD −2%
Givaudan SA GIVN CHF 3,360 CHF 1,527 −55%
Sika AG SIKA CHF 183.80 CHF 98.89 −46%
Wanhua Chemical Group 600309 ¥69.45 ¥68.03 −2%
DSM-Firmenich AG DSFIR CHF 92.30 CHF 29.70 −68%
Asian Paints Limited ASIANPAINT ₹2,444 ₹1,479 −39%

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Scotts Miracle-Gro Co. Fair Value". https://www.fairvalue-calculator.com/stock/0L45

Frequently asked questions

Is Scotts Miracle-Gro Co. (0L45) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $31.37 versus a price of $49.42, about −37% upside (overvalued).
What is the fair value of 0L45?
Our model-based fair value for Scotts Miracle-Gro Co. is $31.37 (as of Sep 24, 2026), built from audited fundamentals. The current price: $49.42.
What is the quality score of 0L45?
Scotts Miracle-Gro Co. has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Scotts Miracle-Gro Co. (0L45)?
Our model-based price target is the fair value of $31.37 (as of Sep 24, 2026) from 19 valuation models. Cautious scenario $17.85, optimistic scenario $53.68. It is a calculation from audited fundamentals, not an analyst target.
What is the Scotts Miracle-Gro Co. stock forecast for 2026?
Our models put fair value at $31.37, about −37% upside versus a price of $49.42 (overvalued). Cautious scenario $17.85, optimistic scenario $53.68. The calculation is refreshed regularly with new filings.
What is the revenue of Scotts Miracle-Gro Co. (0L45)?
Scotts Miracle-Gro Co. reported trailing-twelve-month revenue of about $3.5B (latest available figure, as of Sep 24, 2026).
Does Scotts Miracle-Gro Co. pay a dividend?
Scotts Miracle-Gro Co. currently shows a dividend yield of about 5.34% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Scotts Miracle-Gro Co. (0L45)?
For today's price to be fair in a discounted-cash-flow model, Scotts Miracle-Gro Co. would have to grow free cash flow by +17.6 % per year for five years (discount rate 12.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -3.8 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 0L45 use?
Our models discount Scotts Miracle-Gro Co. at 12.3 %: a base by market capitalisation (unknown), damped by beta 1.80, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Scotts Miracle-Gro Co. that is +17.6 % per year a year over ten years, using the same discount rate (12.3 %) and the same formula as our fair value.
How much growth has Scotts Miracle-Gro Co. (0L45) delivered so far?
Over the past 5 years revenue at Scotts Miracle-Gro Co. grew -3.8 % a year. The price currently implies +17.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Scotts Miracle-Gro Co. (0L45) growing?
The median revenue growth in the sector is +7.0 % a year. That is the yardstick for the growth priced into Scotts Miracle-Gro Co. (+17.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Scotts Miracle-Gro Co. (0L45)?
The free-cash-flow yield on the price is 7.13 %: that much free cash flow Scotts Miracle-Gro Co. produces per unit of market value. When it exceeds the discount rate of our models (12.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Scotts Miracle-Gro Co. (0L45)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Scotts Miracle-Gro Co. it is $31.37 per share (as of Sep 24, 2026), against a price of $49.42. It is the blended result of 19 valuation models (cash flow, earnings, asset, dividend).
Is Scotts Miracle-Gro Co. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0L45 trades above its calculated fair value: price $49.42, fair value $31.37, a gap of about −37% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0L45?
No. The price is what the market pays today ($49.42); the fair value is what the company's own numbers justify ($31.37). For Scotts Miracle-Gro Co. the two are $18.05 per share apart. That gap is exactly why we show both numbers side by side.
How much is Scotts Miracle-Gro Co. worth?
The market values Scotts Miracle-Gro Co. at about $2.9B (market capitalisation, as of Sep 24, 2026). Per share that is $49.42; our models calculate a fair value of $31.37 per share.
What do the bullish and bearish scenarios say about 0L45?
Our models span a range for Scotts Miracle-Gro Co.: cautious scenario $17.85, base $31.37, optimistic $53.68 per share (as of Sep 24, 2026, price $49.42). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0L45?
Scotts Miracle-Gro Co. trades at a price-to-earnings ratio of 0.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $31.37 is built from several models across several years.
How solid is the balance sheet of Scotts Miracle-Gro Co. (0L45)?
Balance-sheet figures for Scotts Miracle-Gro Co. (as of Sep 24, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is 0L45 from its 52-week high?
Scotts Miracle-Gro Co. trades at $49.42, about 34% below its 52-week high of $74.67 and 1% above the low of $49.04 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $31.37 is for.
Which stocks are comparable to Scotts Miracle-Gro Co.?
From the same area (Industrials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Scotts Miracle-Gro Co. stock attractive at the current price?
The data as of Sep 24, 2026: price $49.42, calculated fair value $31.37 (−37%), Quality Score 59/100, from 19 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0L45 calculated?
We run Scotts Miracle-Gro Co. through 19 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $31.37, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Scotts Miracle-Gro Co. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Scotts Miracle-Gro Co. (0L45)?
The closing price on Oct 2, 2026 was $49.42. Our model-based fair value is $31.37, about −37% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Scotts Miracle-Gro Co. right now?
The model range is unusually wide ($17.85 to $53.68). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (59/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Scotts Miracle-Gro Co.

How large is the market capitalisation of Scotts Miracle-Gro Co. (0L45)?
The market capitalisation of Scotts Miracle-Gro Co. is $2.9B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Scotts Miracle-Gro Co. (0L45)?
Earnings per share at Scotts Miracle-Gro Co. are $7.12 (price ÷ EPS = P/E 0.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Scotts Miracle-Gro Co. (0L45)?
The dividend yield of Scotts Miracle-Gro Co. is 5.3% (payout 37.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Scotts Miracle-Gro Co. (0L45)?
The net margin of Scotts Miracle-Gro Co. is 4.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Scotts Miracle-Gro Co. (0L45)?
The return on equity (ROE) of Scotts Miracle-Gro Co. is −47.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Scotts Miracle-Gro Co. (0L45)?
On an EBIT basis the return on assets of Scotts Miracle-Gro Co. is 11.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Scotts Miracle-Gro Co. (0L45)?
The operating margin of Scotts Miracle-Gro Co. is 27.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Scotts Miracle-Gro Co. (0L45)?
Revenue at Scotts Miracle-Gro Co. is growing +5.0% versus a year earlier (3y avg −4.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Scotts Miracle-Gro Co. (0L45)?
Earnings per share at Scotts Miracle-Gro Co. are growing +8.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Scotts Miracle-Gro Co. (0L45) carry?
The net debt of Scotts Miracle-Gro Co. is $2.1B (fiscal year 2025, ≈ 7.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Scotts Miracle-Gro Co. in the live analysis

One click puts Scotts Miracle-Gro Co. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.